Sign in

CIK 0001604191

  • Non-accelerated filer
  • Smaller reporting company

GridAI Technologies Corp.

Sign in to watch
Ticker
GRDX
Exchange
Nasdaq
Industry
Electric & Other Services Combined
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464993860
Phone
+1 561-589-7020
Business address
433 PLAZA REAL, SUITE 275, BOCA RATON, FL
Former names
Entero Therapeutics, Inc., First Wave BioPharma, Inc., AzurRx BioPharma, Inc., BioPharma d'Azur, Inc.
  1. 4 Grant or award Chairman, President and CEO acquired 37,660 shares (grant or award)
  2. 4 Grant or award Chief Financial Officer acquired 19,614 shares (grant or award)
  3. 4 Open-market sale Chief Financial Officer sold 1,676 shares at $0.29 ($486)
  4. 4 Open-market sale President and CEO sold 2,764 shares at $0.29 ($802)
  5. 4 Open-market sale Director sold 10 shares at $0.43 ($4)
  6. 4 Open-market sale Director sold 6,053 shares at $0.30 ($1,816)
  7. 4 Open-market sale Chief Financial Officer sold 1,977 shares at $1.54 ($3,045)
  8. 4 Open-market sale President and CEO sold 3,349 shares at $1.54 ($5,157)
  9. 4 Open-market sale Chief Financial Officer sold 1,975 shares at $2.50 ($4,938)
  10. 4 Open-market sale President and CEO sold 3,347 shares at $2.50 ($8,368)
  11. 4 Grant or award Director acquired 84,745 shares (grant or award)
  12. 4 Grant or award Chief Financial Officer acquired 150,000 shares (grant or award)
  13. 4 Grant or award President and CEO acquired 300,000 shares (grant or award)
  14. 4 Grant or award Director acquired 84,745 shares (grant or award)
  15. 4 Grant or award Director acquired 84,745 shares (grant or award)
  16. 4 Grant or award Director acquired 84,745 shares (grant or award)
  17. 4 Grant or award Director acquired 84,745 shares (grant or award)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 3 of 10 · 181 filings